股骨头坏死用药规律及机制:数据挖掘和网络药理学分析  

Medication rules and mechanism of femoral head necrosis:an analysis based on data mining and network pharmacology

作　　者：王鼎 林天烨 陈伟坚 陈坚锋[1] 欧会芝 李虹竹 杨鹏 魏秋实[5] 何伟[5] 冯宗权[1] Wang Ding;Lin Tianye;Chen Weijian;Chen Jianfeng;Ou Huizhi;Li Hongzhu;Yang Peng;Wei Qiushi;He Wei;Feng Zongquan(Foshan Traditional Chinese Medicine Hospital,Foshan 528000,Guangdong Province,China;The First Clinical School of Guangzhou University of Chinese Medicine,Guangzhou 510405,Guangdong Province,China;Guangzhou Orthopedic Hospital Affiliated to Guangzhou University of Chinese Medicine,Guangzhou 510000,Guangdong Province,China;School of Acupuncture and Rehabilitation,Guangzhou University of Chinese Medicine,Guangzhou 510405,Guangdong Province,China;Department of Joint Orthopedics,First Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510405,Guangdong Province,China)

机构地区：[1]佛山市中医院,广东省佛山市528000 [2]广州中医药大学第一临床医学院,广东省广州市510405 [3]广州中医药大学附属广州市正骨医院,广东省广州市510000 [4]广州中医药大学针灸康复临床医学院,广东省广州市510405 [5]广州中医药大学第一附属医院关节骨科,广东省广州市510405

出　　处：《中国组织工程研究》2021年第32期5148-5154,共7页Chinese Journal of Tissue Engineering Research

基　　金：国家自然科学基金(81873327),课题负责人:何伟;广东省中医药局科研项目(21091116),课题负责人:杨鹏。

摘　　要：背景:中医药物治疗股骨头坏死常作为辅助手段,然而其用药规律、组方原则及作用机制尚不清楚。目的:挖掘并分析广州中医药大学第一附属医院三骨科保髋病区治疗股骨头坏死的中药组方用药规律,并探讨潜在新方组合的作用机制。方法:收集2017年1月至2019年12月广州中医药大学第一附属医院三骨科保髋病区治疗股骨头坏死处方,通过中医传承辅助平台(V2.5)进行数据挖掘,分析处方药物的用药频次、药物关联,并得出潜在中药新方组合。运用TCMSP、String及KEGG数据库对“新处方”中药物靶标间相互作用关系进行分析,并分析所得的相关通路。结果与结论:①共筛选出126首处方,包含84味中药,演化得到4个潜在新方组合(处方1:桃仁-黄芪-牛膝-当归-独活;处方2:川芎-白芍-续断-白术;处方3:三七-茯苓-熟地-丹参-杜仲;处方4:红花-秦艽-补骨脂-党参);②筛选出潜在新方组合1(“新处方”)的主要化学成分有74种(如谷甾醇α1和赤霉素17等);③预测到“新处方”活性成分的作用靶标202个,映射后得出“新处方”治疗股骨头坏死121个潜在靶标(如JUN、AKT1、MAPK1、RELA和白细胞介素6等);④文章中的中药-疾病靶标涉及的KEGG通路主要包括MAPK信号通路、Toll样受体、核转录因子κB信号通路及缺氧诱导因子1信号通路;⑤通过上述数据分析得出,中医药治疗股骨头坏死用药以活血化瘀、滋肝益肾、补益气血为主,辅以通经络、祛风湿等药,“新处方”中药组合显示了多成分、多靶点的药物作用特点,其机制可能是通过参与促进血管生成和调节骨代谢等途径来调控股骨头坏死的发展。BACKGROUND: Traditional Chinese medicine is often used as an auxiliary method in the treatment of femoral head necrosis. However, its medication rules,prescription principles, and mechanism of action are still unclear.OBJECTIVE: To explore the rules of prescriptions for the treatment of femoral head necrosis in the hip-protecting ward of the Third Orthopedics Departmentof the First Affiliated Hospital of Guangzhou University of Chinese Medicine using data mining, and to explore the mechanism of action of potential newprescription combinations.METHODS: From January 2017 to December 2019, the prescriptions for the treatment of femoral head necrosis in the Third Orthopedics Department ofthe First Affiliated Hospital of Guangzhou University of Chinese Medicine were collected. Data mining was conducted through the TCM inheritance auxiliaryplatform (V2.5), and prescription drugs were analyzed with respect to the frequency of medication uses, drug associations, and potential new prescriptioncombinations. TCMSP, String and KEGG databases were used to analyze the interaction relationship between drug targets in the “new prescription” and toanalyze the related pathways obtained.RESULTS AND CONCLUSION: A total of 126 prescriptions were screened, containing 84 Chinese herbs, and 4 potential new prescription combinations wereevolved (prescription 1: peach kernel-astragalus-achyranthes bidentata-angelica-duhuo;prescription 2: Chuanxiong-white peony-dipsacus- atractylodes;prescription 3: Panax notoginseng-poria-rehmannia-salvia-eucommia;prescription 4: safflower-gentiana-psoralen-codonopsis). There were 74 main chemicalcomponents (sitosterol α1, gibberellin 17, etc.) of potential new prescription combination 1 (“new prescription”). This study predicted that there were 202targets for the active ingredients of the “new prescription,” and 121 potential targets for the treatment of femoral head necrosis were obtained after mapping,such as JUN, AKT1, MAPK1, RELA, interleukin-6, etc. The Kyoto Encyclopedia of Genes and G

关 键 词：骨 股骨 股骨头坏死 髋 中药 数据挖掘 网络药理学 分子机制 信号通路 

分 类 号：R453[医药卫生—治疗学] R285[医药卫生—临床医学]